首页 > 最新文献

European Journal of Cancer最新文献

英文 中文
Congruence of Tumor Characteristics between Preoperative Biopsy and Surgical Excision Specimen for Small Breast Tumors: CONSCIENCE 小型乳腺肿瘤术前活检与手术切除标本的肿瘤特征一致性:一致性
Pub Date : 2024-03-01 DOI: 10.1016/j.ejca.2024.113788
S. Wooldrik
{"title":"Congruence of Tumor Characteristics between Preoperative Biopsy and Surgical Excision Specimen for Small Breast Tumors: CONSCIENCE","authors":"S. Wooldrik","doi":"10.1016/j.ejca.2024.113788","DOIUrl":"https://doi.org/10.1016/j.ejca.2024.113788","url":null,"abstract":"","PeriodicalId":505596,"journal":{"name":"European Journal of Cancer","volume":"241 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140280271","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
AKT1, ERBB2, ESR1, KRAS, PIK3CA and TP53 alteration detection by a new ctDNA assay in plasma of patients with hormone receptor positive (HR+)/HER2- advanced Breast Cancer treated with hormonal therapy and CDK4/6 inhibitors 在接受激素疗法和 CDK4/6 抑制剂治疗的激素受体阳性 (HR+)/HER2- 晚期乳腺癌患者血浆中,通过新型 ctDNA 检测法检测 AKT1、ERBB2、ESR1、KRAS、PIK3CA 和 TP53 的改变
Pub Date : 2024-03-01 DOI: 10.1016/j.ejca.2024.113807
A. Virga, C. Gianni, M. Palleschi, F. Merloni, R. Maltoni, P. Ulivi, U. De Giorgi, G. Martinelli, S. Bravaccini
{"title":"AKT1, ERBB2, ESR1, KRAS, PIK3CA and TP53 alteration detection by a new ctDNA assay in plasma of patients with hormone receptor positive (HR+)/HER2- advanced Breast Cancer treated with hormonal therapy and CDK4/6 inhibitors","authors":"A. Virga, C. Gianni, M. Palleschi, F. Merloni, R. Maltoni, P. Ulivi, U. De Giorgi, G. Martinelli, S. Bravaccini","doi":"10.1016/j.ejca.2024.113807","DOIUrl":"https://doi.org/10.1016/j.ejca.2024.113807","url":null,"abstract":"","PeriodicalId":505596,"journal":{"name":"European Journal of Cancer","volume":"449 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140281057","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictive value of contrast enhanced spectral mammography (CESM) and mammotome guided biopsy of clipped tumour in determining pathological complete response following neoadjuvant chemotherapy in breast cancer patients 乳腺癌患者新辅助化疗后,对比增强光谱乳腺 X 射线造影术 (CESM) 和乳腺切片引导下的肿瘤切片检查在确定病理完全反应方面的预测价值
Pub Date : 2024-03-01 DOI: 10.1016/j.ejca.2024.113859
S.S.H. Phua, P. Chan, E.Y. Tan, J. Chen, E.J. Sim
{"title":"Predictive value of contrast enhanced spectral mammography (CESM) and mammotome guided biopsy of clipped tumour in determining pathological complete response following neoadjuvant chemotherapy in breast cancer patients","authors":"S.S.H. Phua, P. Chan, E.Y. Tan, J. Chen, E.J. Sim","doi":"10.1016/j.ejca.2024.113859","DOIUrl":"https://doi.org/10.1016/j.ejca.2024.113859","url":null,"abstract":"","PeriodicalId":505596,"journal":{"name":"European Journal of Cancer","volume":"156 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140282234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Prospective, Single arm, Multicentre, Post-marketing Study (Phase IV) to evaluate safety and immunogenicity of Dr. Reddy’s Trastuzumab (DRL_TZ) in Patients with HER2-Positive Advanced Breast Cancer 一项前瞻性、单臂、多中心、上市后研究(IV 期),评估 Dr. Reddy's 曲妥珠单抗 (DRL_TZ) 在 HER2 阳性晚期乳腺癌患者中的安全性和免疫原性
Pub Date : 2024-03-01 DOI: 10.1016/j.ejca.2024.113709
S. Nag, C. Deshmukh, M. Jain, P. Reddy, N. Reddy, N. Maharaj, R. Desai, V. Natarajan, K. Gaurav
{"title":"A Prospective, Single arm, Multicentre, Post-marketing Study (Phase IV) to evaluate safety and immunogenicity of Dr. Reddy’s Trastuzumab (DRL_TZ) in Patients with HER2-Positive Advanced Breast Cancer","authors":"S. Nag, C. Deshmukh, M. Jain, P. Reddy, N. Reddy, N. Maharaj, R. Desai, V. Natarajan, K. Gaurav","doi":"10.1016/j.ejca.2024.113709","DOIUrl":"https://doi.org/10.1016/j.ejca.2024.113709","url":null,"abstract":"","PeriodicalId":505596,"journal":{"name":"European Journal of Cancer","volume":"88 11","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140276433","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Utility of clinical-pathological parameters for exclusion of BRCA1/2 mutation carriers as candidates for partial breast irradiation 临床病理参数对排除 BRCA1/2 基因突变携带者作为乳腺部分照射候选者的实用性
Pub Date : 2024-03-01 DOI: 10.1016/j.ejca.2024.113729
R. Bernstein Molho, N. Abu-Shehada, E. Gal-Yam, Z. Zippel, T. Menes, M. Sklair-Levy, S. Galper, O. Kaidar-Person
{"title":"Utility of clinical-pathological parameters for exclusion of BRCA1/2 mutation carriers as candidates for partial breast irradiation","authors":"R. Bernstein Molho, N. Abu-Shehada, E. Gal-Yam, Z. Zippel, T. Menes, M. Sklair-Levy, S. Galper, O. Kaidar-Person","doi":"10.1016/j.ejca.2024.113729","DOIUrl":"https://doi.org/10.1016/j.ejca.2024.113729","url":null,"abstract":"","PeriodicalId":505596,"journal":{"name":"European Journal of Cancer","volume":"102 7","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140278263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real-world analysis of genomic signature indications and impact on adjuvant chemoendocrine therapy (CET) decisions: experience from the French LISE cohort (n = 301) 基因组特征适应症及其对辅助化疗内分泌疗法 (CET) 决策影响的实际分析:来自法国 LISE 队列(n = 301)的经验
Pub Date : 2024-03-01 DOI: 10.1016/j.ejca.2024.113867
B. Cutuli, C. Charles, F. Bancheri, Y. Caron, D. Coeffic, P. Colin, P.H. Dorangeon, S. Ferrand, N. Gavillon, C.G. Hemery, N. Jovenin, L. Krebs, A.R. Majidi, F. Mallet, W. Mina, K. Prulhiere-Corviole, P. Terrosi, A. Theillier, I. Veron-Leclercq, G. Yazbek
{"title":"Real-world analysis of genomic signature indications and impact on adjuvant chemoendocrine therapy (CET) decisions: experience from the French LISE cohort (n = 301)","authors":"B. Cutuli, C. Charles, F. Bancheri, Y. Caron, D. Coeffic, P. Colin, P.H. Dorangeon, S. Ferrand, N. Gavillon, C.G. Hemery, N. Jovenin, L. Krebs, A.R. Majidi, F. Mallet, W. Mina, K. Prulhiere-Corviole, P. Terrosi, A. Theillier, I. Veron-Leclercq, G. Yazbek","doi":"10.1016/j.ejca.2024.113867","DOIUrl":"https://doi.org/10.1016/j.ejca.2024.113867","url":null,"abstract":"","PeriodicalId":505596,"journal":{"name":"European Journal of Cancer","volume":"76 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140279377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative study between using ultrasound dissecting device or electrocautery in modified radical mastectomy 改良根治性乳房切除术中使用超声剥离装置还是电烧的比较研究
Pub Date : 2024-03-01 DOI: 10.1016/j.ejca.2024.113793
G. AbouElnagah
{"title":"Comparative study between using ultrasound dissecting device or electrocautery in modified radical mastectomy","authors":"G. AbouElnagah","doi":"10.1016/j.ejca.2024.113793","DOIUrl":"https://doi.org/10.1016/j.ejca.2024.113793","url":null,"abstract":"","PeriodicalId":505596,"journal":{"name":"European Journal of Cancer","volume":"185 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140281887","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metronomic treatment significantly enhanced cytotoxicity in palbociclib-resistant ER-positive breast cancer cell lines 配伍治疗可明显增强帕博西尼(palbociclib)耐药ER阳性乳腺癌细胞系的细胞毒性
Pub Date : 2024-03-01 DOI: 10.1016/j.ejca.2024.113825
N. Sherif, A. Ilari, N. Cordani, E. Grassilli, M.E. Cazzaniga, M. Lavitrano, M. Cerrito
{"title":"Metronomic treatment significantly enhanced cytotoxicity in palbociclib-resistant ER-positive breast cancer cell lines","authors":"N. Sherif, A. Ilari, N. Cordani, E. Grassilli, M.E. Cazzaniga, M. Lavitrano, M. Cerrito","doi":"10.1016/j.ejca.2024.113825","DOIUrl":"https://doi.org/10.1016/j.ejca.2024.113825","url":null,"abstract":"","PeriodicalId":505596,"journal":{"name":"European Journal of Cancer","volume":"225 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140278680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Machine learning model predicting axillary pathologic response after neoadjuvant chemotherapy for clinically node-positive breast cancer 预测临床结节阳性乳腺癌新辅助化疗后腋窝病理反应的机器学习模型
Pub Date : 2024-03-01 DOI: 10.1016/j.ejca.2024.113742
A. Matsumoto, M. Sugimoto, S. Naruse, Y. Isono, Y. Maeda, A. Sato, M. Yamada, T. Ikeda, H. Jinno
{"title":"Machine learning model predicting axillary pathologic response after neoadjuvant chemotherapy for clinically node-positive breast cancer","authors":"A. Matsumoto, M. Sugimoto, S. Naruse, Y. Isono, Y. Maeda, A. Sato, M. Yamada, T. Ikeda, H. Jinno","doi":"10.1016/j.ejca.2024.113742","DOIUrl":"https://doi.org/10.1016/j.ejca.2024.113742","url":null,"abstract":"","PeriodicalId":505596,"journal":{"name":"European Journal of Cancer","volume":"518 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140281757","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidemiology of HER2-low breast cancer in Lithuania 立陶宛 HER2 低水平乳腺癌流行病学
Pub Date : 2024-03-01 DOI: 10.1016/j.ejca.2024.113843
A. Cesas, L. Poskiene, R.B. Valkiuniene, L. Radvinskiene, I. Lege
{"title":"Epidemiology of HER2-low breast cancer in Lithuania","authors":"A. Cesas, L. Poskiene, R.B. Valkiuniene, L. Radvinskiene, I. Lege","doi":"10.1016/j.ejca.2024.113843","DOIUrl":"https://doi.org/10.1016/j.ejca.2024.113843","url":null,"abstract":"","PeriodicalId":505596,"journal":{"name":"European Journal of Cancer","volume":"52 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140274591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
European Journal of Cancer
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1